(人工智能开发治疗癌症方法.docVIP

不用化疗，一家公司正利用人工智能开发治癌新方法 人类能否在两三年内治愈癌症？波士顿伯格公司通过一个人工智能平台，开发出了第一款新药——BPM 31510，目前进入临床测试阶段。它可以重组癌细胞的新陈代谢，使患者不必经历化疗，让癌细胞自然死亡。一名膀胱癌患者在进行药物测试18周后，肿瘤已经完全消失了。 Could we be just two or three years away from curing cancer? Niven Narain, the president of Berg, a small Boston-based biotech firm, says that may very well be the case. ????With funding from billionaire real-estate tycoon Carl Berg as well as from Mitch Gray, Narain, a medical doctor by training, and his small army of scientists, technicians, and programmers, have spent the last six years perfecting and testing an artificial intelligence platform that he believes could soon crack the cancer code, in addition to discovering valuable information about a variety of other terrible diseases, including Parkinson’s. ????Thanks to partnerships formed with universities, hospitals, and even the U.S. Department of Defense, Berg and its supercomputers have been able to analyze thousands of patient records and tissue samples to find possible new drug targets and biomarkers. ????All this data crunching has led to the development of Berg’s first drug, BPM 31510, which is in clinical trials. The drug acts by essentially reprogramming the metabolism of cancer cells, re-teaching them to undergo apoptosis, or cell death. In doing so, the cancer cells die off naturally, without the need for harmful and expensive chemotherapy. ????So far, Berg has concentrated most of its resources on prostate cancer, given the large amount of data available on the disease. But thanks to recently announced partnerships, the firm is now building a new modeltargeting pancreatic cancer, which is one of the deadliest forms of cancers with a survivorship rate of only 7%. ????Ambitious as that may be, it is really just the tip of the iceberg. In addition to mapping out prostate and pancreatic cancer, Berg hopes to analyze data from a whole host of other diseases, including breast cancer. Additionally, Berg thinks his company’s artificial intelligence platfor